The automotive industry plays a critical role in the global economy, and particularly important is the expanding Chinese automobile market due to its immense scale and influence. However, existing automotive sector datasets are limited in their coverage, failing to adequately consider the growing demand for more and diverse variables. This paper aims to bridge this data gap by introducing a comprehensive dataset spanning the years from 2016 to 2022, encompassing sales data, online reviews, and a wealth of information related to the Chinese automotive industry. This dataset serves as a valuable resource, significantly expanding the available data. Its impact extends to various dimensions, including improving forecasting accuracy, expanding the scope of business applications, informing policy development and regulation, and advancing academic research within the automotive sector. To illustrate the dataset's potential applications in both business and academic contexts, we present two application examples. Our developed dataset enhances our understanding of the Chinese automotive market and offers a valuable tool for researchers, policymakers, and industry stakeholders worldwide.

The latest Digital Health news industry round-up includes an award of £1.4m for Mendelian to further develop its AI solutions, a pilot for a state-of-the-art prehabilitation programme at James Paget University Hospitals and the launch of Spex Capital's €100m health tech fund. A 2023 report on the clinical alarm management market by Future Market Insights has named Tutum Medical's Bedside Equipment Alarm Monitoring System (BEAMS) as a recent development in the market to watch. The reports says: "Sheffield Children's Hospital announced a collaboration with Tutum Medical in March 2017 to create a revolutionary design for a Bedside Equipment Alarm Monitoring System (BEAMS). The system provides crucial bedside equipment monitoring to improve nursing staff response times to alarms. The solution is expected to cut alarm response time by up to 95%, considerably lowering alarm fatigue and enhancing staff availability to serve important patients effectively."

The world is going nuts over AI and tools built on it. They plunge into this area and can't help consuming more and more info about it, and are even creating their own intelligent products. To help you catch up on the latest news on the AI industry, we've selected Twitter accounts that are both top-rated and trending. This account needs no introduction, as it is curated by the industry leader in AI. Getting the news straight from the horse's mouth is worth your time.

This Digital Health News industry roundup includes a new online course for young people to build skills for a future career in care, a milestone for digital-first healthcare-at-home company Cera and the integration of Ibex Medical Analytics' AI platform with Source BioScience's pathology network. A partnership between Babyl – a subsidiary of Babylon – and Novo Nordisk will help contribute to the expansion of diabetes awareness and care in Rwanda through community engagement and skills building using digital technology. Babyl's existing infrastructure and digital tech will be used to offer digital consultations to patients across Rwanda. Patients who then receive a confirmed diagnosis will be guided to the correct level of care by a doctor or nurse. This could include medication or a referral for further tests.

This Digital Health News industry roundup includes an IT award for the Department of Health and Social Care and Netcompany for the NHS Covid Pass, accreditation for an AI device and a virtual falls service keeping care home residents out of hospital. Digital health and AI company Empatica has received clearance of its Empatica Health Monitoring Platform by the US Food and Drug Administration (FDA). The platform has been cleared for continuous data collection to monitor blood oxygen saturation during rest, peripheral skin temperature, activity associated with movement during sleep and electrodermal activity. Each digital biomarker is based on trained algorithms that analyse sensor data in one-minute intervals. Dr. Marisa Cruz, chief medical officer of Empatica, said: "This clearance represents a significant step forward for our scientific community. Patients, healthcare providers, and researchers deserve digital health products that are accurate, validated in diverse populations, and intuitive to use. "We are proud to have built a solution that accomplishes these goals, offering a high-quality and reliable digital health tool to scientists working to improve patient outcomes through research and clinical care." The company has also announced the closing of its Series B financing. The investment was led by Sanofi Venture and RA Capital Management with participation by Black Opal Ventures. Empatica intends to use the financing to expand its suite of digital biomarkers for use in both patient care and in clinical trials as digital endpoints. Cris De Luca, partner at Sanofi Ventures and newly-appointed board member at Empatica, said: "By gaining higher resolution into disease symptomology through novel digital measures and digital biomarkers in clinical and real-world settings, Empatica is unlocking the possibilities of early disease detection, enhanced treatment decisions, and improving quality of life for patients around the world." International IT services company, Netcompany, alongside the Department for Health and Social Care (DHSC) have won the Emerging Technology of the Year award in the Technology Excellence category of the 2022 UK IT Industry Awards. The two companies were recognised for their work on the NHS Covid Pass, which also saw them receive a highly commended in the Best Healthcare IT Project of the Year 2022. The win reflects the vital role that the NHS Covid Pass has played in the safe reopening of the country. It allows users to shared their Covid-19 status or vaccination status when travelling internationally. Richard Davies, UK country managing partner at Netcompany, said: "This award recognises our talented teams, expertise, and dedication towards creating technology solutions that help to improve the everyday lives of citizens.

This edition of Digital Health News industry round-up includes projects focusing on artificial intelligence (AI), an app to tackle health inequalities and a project to use primary care data to help eradicate hepatitis C. The Royal Marsden NHS Foundation Trust and the Francis Crick Institute are working with AI start-up Owkin to gain a better understanding of how kidney cancers evolve to help improve treatment for the disease. By studying the evolutionary features of a tumour and understanding how it has evolved through a series of genetic changes over time, scientists hope to help doctors predict a patient's outcome, meaning they can tailor treatment to individuals to improve health outcomes. Dr Samra Turajlic, group leader at the Francis Crick Institute and consultant medical oncologist at The Royal Marsden NHS Foundation Trust, said: "We know that the outcomes of any individual patient with kidney cancer are determined by the distinct way their tumour evolves. We want to be able to predict the next step in a tumour's evolutionary trajectory and better tailor treatments that can effectively tackle a patient's cancer. "New technologies and tools are critical in helping us achieve this at a scale and speed that is required in clinical practice, and at a cost that will make these measurements implementable in most healthcare systems." It hopes that it will be able to draw links between the histological characteristics of a tumour with patient outcomes. This will also support the move to precision medicine. The project will use rapid and low-cost AI on digital pathology, helping the day-to-day management of patients in a cost-effective way. Thomas Clozel, co-founder and CEO of Owkin, said: "By using AI to improve our fundamental understanding of cancer tumours, we aim to enable doctors to move towards a precision medicine approach to treatment.

Although the Covid-19 pandemic persisted throughout the year, the healthcare industry continued to fulfill its duty based on experiences of last year. While going all out to develop Covid-19 treatments and vaccines, the industry tried to graft new technologies, including AI, to promote the sector's development. In the process, the industry revealed problems requiring correction, such as manipulating raw materials and impurities caught in antihypertensive drugs. Still, the sector continued to improve itself in keeping with the changing global healthcare industry amid the Covid-19 crisis. Korea Biomedical Review has compiled the five biggest industry stories in 2021.

The latest Digital Health News Industry round up includes details on a name change, a robotic surgical systems installation and the launch of digital pre-op assessments for one trust. The Midlands Partnership NHS Foundation Trust has selected Agilisys to develop a business intelligence strategy to enhance the trust's data and analytics capabilities. As a result, the trust will have a single business intelligence tool that can be used across the whole of Midlands Partnership NHS Foundation Trust (MPFT). Previously this information was used by just the Business Intelligence Team but by making it available trust-wide, regardless of skill-level, it will support massive growth in the trust's data warehouse. In turn, this will support MPFT's ambitions for HIMSS 7. The two organisations are now working together on delivering a roadmap that informs the trust's decisions on migrating its data to the cloud.

The latest Digital Health News industry round up includes news on an automated recruitment platform for clinical studies, an acquisition in the medical imaging field and an Australian company focused on measuring coding launching into the UK. Former NHS leader, Tim Kelsey, has launched an international division of Beamtree into the UK – an Australian company that focuses on measuring coding and the quality of hospital care. Kelsey leads the Australian company, but the new London-based arm will be led by coding policy expert Jennifer Nobbs and former Paterson Inquiry advisor Alex Kafetz. Beamtree works with health organisations around the world in a bid to improve the capture, management and leverage of human expertise. The UK office will focus on AI in health, clinical decision support, data quality and analytics supporting better health outcomes.

Retailers continue to lead the way in AI investments, as personalization becomes a more important driver of e-commerce sales and consumers demand better customer experiences, including those delivered by automated agents like chatbots and business messengers.